Rejected at 7:13 p.m. Oct, 31, 2023 ] by Tahseen
Author: jphillips767
Related Note: 1484950376874
Rationale for change

clarity for cloze

Rejection reason

unnecessary

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#UWorld::COMLEX::101293 #AK_Step1_v12::#UWorld::Step::1287 #AK_Step1_v12::#Pixorize::3_Pharmacology::9_Psych_Drugs_(New)::7_Buprenorphine #AK_Step2_v12::#AMBOSS::vCaAF5 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention::02_Buprenorphine #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::30_Opioid_Withdrawal,_Detoxification_and_Relapse_Prevention #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::03_Opioids #PANCE::EOR::PSYCH #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#AMBOSS::ViaGq4 #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::16_Butorphanol_nalbuphine #AK_Step2_v12::!Shelf::EM #AK_Step2_v12::#UWorld::Step::4509 #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::16_Butorphanol_nalbuphine::02_Clinical_Use::*Mixed_Agonist_&_Antagonist_Opioid_Analgesics::Buprenorphine #AK_Step1_v12::#B&B::19_Psych::03_Substance_Use_Disorders::02_Opioids #AK_Step1_v12::#UWorld::COMLEX::24398 #AK_Step2_v12::#UWorld::COMLEX::106892 #AK_Step1_v12::#AMBOSS::yy0d3i #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::17_Full_Opioid_Agonists #AK_Step2_v12::#SketchyPsych::10_Substance_Use/_Medication_Related_Disorders::01_Substance_Use_Overview #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention::01_Methadone #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::01_Anesthetics_&_Analgesics::03_Opiates,_Naloxone,_Naltrexone #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::21_Opioid_Clinical_Use,_Mechanism_and_Overdose #AK_Step2_v12::#B&B::13_Psych::03_Substance_Abuse::02_Substance_Abuse_I #AK_Step2_v12::#UWorld::Step::105856 #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::16_Butorphanol_nalbuphine::02_Clinical_Use::*Mixed_Agonist_&_Antagonist_Opioid_Analgesics::Methadone #PANCE::BEHAVIORAL::substance_use #AK_Step1_v12::#Pixorize::^Missing_image